loading
Schlusskurs vom Vortag:
$12.42
Offen:
$12.58
24-Stunden-Volumen:
1.46M
Relative Volume:
1.09
Marktkapitalisierung:
$1.27B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-137.25M
KGV:
-6.9312
EPS:
-1.89
Netto-Cashflow:
$-121.97M
1W Leistung:
+2.50%
1M Leistung:
+25.24%
6M Leistung:
+152.41%
1J Leistung:
+55.21%
1-Tages-Spanne:
Value
$12.47
$13.38
1-Wochen-Bereich:
Value
$11.71
$13.38
52-Wochen-Spanne:
Value
$3.8951
$14.93

Oric Pharmaceuticals Inc Stock (ORIC) Company Profile

Name
Firmenname
Oric Pharmaceuticals Inc
Name
Telefon
(650) 388-5600
Name
Adresse
240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA
Name
Mitarbeiter
128
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
ORIC's Discussions on Twitter

Vergleichen Sie ORIC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ORIC
Oric Pharmaceuticals Inc
13.10 1.21B 0 -137.25M -121.97M -1.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.39 108.36B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
463.43 60.82B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.95 61.02B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
817.32 50.01B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.81 34.05B 4.56B -176.77M 225.30M -1.7177

Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-04 Fortgesetzt Guggenheim Buy
2025-07-08 Eingeleitet Ladenburg Thalmann Buy
2024-10-31 Eingeleitet Wells Fargo Overweight
2024-09-06 Eingeleitet Stifel Buy
2024-02-23 Eingeleitet Cantor Fitzgerald Overweight
2023-09-22 Eingeleitet Wedbush Outperform
2023-03-23 Hochstufung H.C. Wainwright Neutral → Buy
2023-03-21 Hochstufung Guggenheim Neutral → Buy
2023-03-16 Hochstufung Oppenheimer Perform → Outperform
2022-07-18 Fortgesetzt Oppenheimer Perform
2022-04-04 Hochstufung Citigroup Neutral → Buy
2022-03-25 Herabstufung H.C. Wainwright Buy → Neutral
2022-03-22 Herabstufung Citigroup Buy → Neutral
2022-03-22 Herabstufung Guggenheim Buy → Neutral
2022-03-22 Herabstufung Oppenheimer Outperform → Perform
2021-07-06 Hochstufung Citigroup Neutral → Buy
2021-01-25 Herabstufung Citigroup Buy → Neutral
2020-08-13 Eingeleitet Robert W. Baird Outperform
2020-08-06 Hochstufung Citigroup Neutral → Buy
2020-08-03 Eingeleitet H.C. Wainwright Buy
2020-05-19 Eingeleitet Citigroup Neutral
2020-05-19 Eingeleitet Guggenheim Buy
2020-05-19 Eingeleitet JP Morgan Overweight
2020-05-19 Eingeleitet Jefferies Buy
Alle ansehen

Oric Pharmaceuticals Inc Aktie (ORIC) Neueste Nachrichten

pulisher
04:46 AM

Oric Pharmaceuticals' (ORIC) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat

04:46 AM
pulisher
04:16 AM

Will ORIC Pharmaceuticals Inc. stock split again soonTrade Analysis Report & Reliable Entry Point Trade Alerts - newser.com

04:16 AM
pulisher
01:35 AM

What technical models suggest about ORIC Pharmaceuticals Inc.’s comebackJuly 2025 Sector Moves & Weekly Market Pulse Updates - newser.com

01:35 AM
pulisher
01:25 AM

Why ORIC Pharmaceuticals Inc. (4TZ) stock stays on top picksTrade Analysis Summary & Weekly Top Performers Watchlists - newser.com

01:25 AM
pulisher
Oct 25, 2025

Has ORIC Pharmaceuticals Inc. found a price floorJuly 2025 Setups & Technical Confirmation Trade Alerts - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Relative strength of ORIC Pharmaceuticals Inc. in sector analysisWeekly Gains Summary & AI Forecast for Swing Trade Picks - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Sentiment analysis tools applied to ORIC Pharmaceuticals Inc.July 2025 Retail & Risk Controlled Stock Pick Alerts - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

How to read the order book for ORIC Pharmaceuticals Inc.July 2025 Review & Real-Time Chart Breakout Alerts - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Can you recover from losses in ORIC Pharmaceuticals Inc.2025 Breakouts & Breakdowns & Community Shared Stock Ideas - newser.com

Oct 25, 2025
pulisher
Oct 24, 2025

Oric Pharmaceuticals, Inc. (ORIC) Investor Outlook: A Promising 47% Upside Potential Amid Innovative Cancer Therapies - DirectorsTalk Interviews

Oct 24, 2025
pulisher
Oct 23, 2025

BDTX vs. ORIC: Which Oncology Focused Biotech Stock Is a Better Pick Now? - sharewise.com

Oct 23, 2025
pulisher
Oct 22, 2025

TD Asset Management Inc Raises Position in Oric Pharmaceuticals, Inc. $ORIC - MarketBeat

Oct 22, 2025
pulisher
Oct 21, 2025

Historical volatility pattern of ORIC Pharmaceuticals Inc. visualizedWeekly Profit Report & Verified Technical Trade Signals - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Candlestick signals on ORIC Pharmaceuticals Inc. stock todayEarnings Summary Report & Capital Efficient Trading Techniques - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Analyzing drawdowns of ORIC Pharmaceuticals Inc. with statistical tools2025 Winners & Losers & Weekly Consistent Profit Watchlists - newser.com

Oct 21, 2025

Finanzdaten der Oric Pharmaceuticals Inc-Aktie (ORIC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Oric Pharmaceuticals Inc-Aktie (ORIC) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Piscitelli Dominic
Chief Financial Officer
Oct 06 '25
Sale
14.52
11,000
159,719
48,317
Chacko Jacob
PRESIDENT AND CEO
Oct 06 '25
Sale
12.32
37,461
461,520
531,419
$37.26
price up icon 1.11%
$91.28
price up icon 2.21%
$29.89
price up icon 0.07%
$105.66
price up icon 0.87%
$159.66
price down icon 0.29%
biotechnology ONC
$310.81
price up icon 0.25%
Kapitalisierung:     |  Volumen (24h):